Gene · 4481
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-Wide Association Studies of 3 Distinct Recovery Phenotypes in Mild Ischemic Stroke. | Neurology | 2024 | 38181310 | PubTator, text mining | PubMed |
| Identification of female-enriched and disease-associated microglia (FDAMic) contributes to sexual dimorphism in late-onset Alzheimer's disease. | J Neuroinflammation | 2024 | 38178204 | PubTator, text mining | PubMed |
| CD204-positive M2-like tumor-associated macrophages increase migration of gastric cancer cells by upregulating miR-210 to reduce NTN4 expression. | Cancer Immunol Immunother | 2024 | 38175202 | PubTator, text mining | PubMed |
| Computational pathology identifies immune-mediated collagen disruption to predict clinical outcomes in gynecologic malignancies. | Commun Med (Lond) | 2024 | 38172536 | PubTator, text mining | PubMed |
| Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma. | Theranostics | 2024 | 38169544 | PubTator, text mining | PubMed |
| Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation. | Lung Cancer | 2024 | 38160515 | PubTator, text mining | PubMed |
| Effect of ubiquitin protease system on DNA damage response in prostate cancer (Review). | Exp Ther Med | 2024 | 38125344 | PubTator, text mining | PubMed |
| Potential promising anticancer applications of β-glucans: a review. | Biosci Rep | 2024 | 38088444 | PubTator, text mining | PubMed |
| Pan-Cancer Single-Nucleus Total RNA Sequencing Using snHH-Seq. | Adv Sci (Weinh) | 2024 | 38010945 | PubTator, text mining | PubMed |
| Correlation of Neuroendocrine Differentiation with a Distinctively Suppressive Immune Microenvironment in Gastric Cancer. | Neuroendocrinology | 2024 | 37827134 | PubTator, text mining | PubMed |
| Integrated bulk and single-cell transcriptome data identify clinically relevant cell populations in clear cell renal cell carcinoma. | Genes Dis | 2024 | 37588222 | PubTator, text mining | PubMed |
| Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study). | Clin Cancer Res | 2024 | 37527007 | PubTator, text mining | PubMed |
| Tumor-associated macrophages in canine visceral hemangiosarcoma. | Vet Pathol | 2024 | 37341055 | PubTator, text mining | PubMed |
| Preliminary Study of the Relationship between Osteopontin and Relapsed Hodgkin's Lymphoma. | Biomedicines | 2023 | 38275392 | PubTator, text mining | PubMed |
| Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy. | Front Immunol | 2023 | 38274827 | PubTator, text mining | PubMed |
| Identification of a novel, MSC-induced macrophage subtype via single-cell sequencing: implications for intervertebral disc degeneration therapy. | Front Cell Dev Biol | 2023 | 38274272 | PubTator, text mining | PubMed |
| PCSK-9 inhibitors: a new direction for the future treatment of ischemic stroke. | Front Pharmacol | 2023 | 38273837 | PubTator, text mining | PubMed |
| Beyond boundaries: unraveling innovative approaches to combat bone-metastatic cancers. | Front Endocrinol (Lausanne) | 2023 | 38260135 | PubTator, text mining | PubMed |
| Lipid peroxidation of immune cells in cancer. | Front Immunol | 2023 | 38259464 | PubTator, text mining | PubMed |
| Current understanding of macrophages in intracranial aneurysm: relevant etiological manifestations, signaling modulation and therapeutic strategies. | Front Immunol | 2023 | 38259443 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4481/papers?page=12